Emerging Markets

Emerging markets face unique challenges in accessing medicines and medical technologies.

Image Critique Hill
Publication

A Critique of the Paper “The Estimated Costs of Production and Potential Prices for the World Health Organization Essential Medicines List”

1 May 2018

This OHE Consulting Report reviews “Estimated costs of production and potential prices of medicines for the World Health Organization Essential Medicines List” (Hill et al., 2018)…

News

Effect of Religion on the Perception of Health States: A Qualitative Study

22 November 2017

Just published in BMJ Open: The effect of religion on the perception of health states among adults in the United Arab Emirates

News

HTAi Asia Policy Forum Briefing Papers: Value and Affordability, Transferability, and Delivery of High Quality HTA for Decision Making

2 May 2017

The fourth annual meeting of the HTAi Asia Policy Forum was held in November 2016. OHE produced Background Briefing Papers for each of these four meetings…

News

Recently Published: Reports on Policy Options for Formulary Development in Middle-income Countries and A Case Study from Mexico

4 January 2017

OHE has published a new report discussing a framework to help middle-income countries efficiently identify medicines for formulary inclusion. A second publication applies this framework to…

Middle Income Countries front page v4
Publication

Policy Options for Formulary Development in Middle-income Countries

1 January 2017

PhRMA commissioned OHE Consulting to explore options and recommend methods that could help middle-income countries efficiently and effectively identify medicines for formulary inclusion. This report presents a framework…

Mexico front page v2
Publication

Policy Options for Formulary Development in Middle-income Countries: Mexico Case Study

1 January 2017

PhRMA commissioned OHE Consulting to explore options and recommend methods that could help middle-income countries efficiently and effectively identify medicines for formulary inclusion. In a previous…

News

OHE at AES 2016: Early Access Schemes, Equity Adjusted QALYs, Multi-indication Pricing and Formulary Development

2 August 2016

The Spanish Health Economics Association (AES) Conference was held at the University of Murcia, 15-18th June 2016. The topic of the meeting was “Reforms under the…

News

OHE at ISPOR Latin America: Policy Options for Formulary Development in Middle-income Countries

20 October 2015

This post summarises OHE’s activities at this year’s ISPOR Latin America conference in Santiago, September 2015. Topics include policy options for formulary development in middle-income countries,…

News

OHE at HTAi Oslo: A New Drug Development Paradigm, a Framework for Developing Formularies in MICs, and the Effect of NICE Decisions Abroad

15 June 2015

This post summarises OHE’s activities at the upcoming HTAi meeting in Oslo, June 2015. Topics include the effect of NICE decisions abroad, a framework for developing…